Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Health Catalyst (HCAT) Receivables - Other (2018 - 2025)

Health Catalyst (HCAT) has disclosed Receivables - Other for 8 consecutive years, with $8.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Receivables - Other rose 2.41% year-over-year to $8.5 million, compared with a TTM value of $8.5 million through Sep 2025, up 2.41%, and an annual FY2024 reading of $11.8 million, up 151.06% over the prior year.
  • Receivables - Other was $8.5 million for Q3 2025 at Health Catalyst, down from $8.7 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $11.8 million in Q4 2024 and bottomed at $500000.0 in Q2 2022.
  • Average Receivables - Other over 5 years is $3.8 million, with a median of $1.8 million recorded in 2023.
  • The sharpest move saw Receivables - Other plummeted 58.33% in 2022, then surged 422.22% in 2023.
  • Year by year, Receivables - Other stood at $800000.0 in 2021, then grew by 12.5% to $900000.0 in 2022, then soared by 422.22% to $4.7 million in 2023, then skyrocketed by 151.06% to $11.8 million in 2024, then decreased by 27.97% to $8.5 million in 2025.
  • Business Quant data shows Receivables - Other for HCAT at $8.5 million in Q3 2025, $8.7 million in Q2 2025, and $7.7 million in Q1 2025.